Delivery Order SPE2DB25D7067-SPE2DB26FSUEJ
- Not listed
- The Defense Logistics Agency awarded a $8,059.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The work will be performed in Conshohocken, Pennsylvania, where the contractor maintains...
- The Defense Logistics Agency awarded a $1,654.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 20, 2025, with a completion date of September 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The order will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $9,274.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of October 10, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product, with a completion date of August 21, 2025. This competitive award (no set-aside used) was issued under a firm fixed-price structure and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $16.87K delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 15, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, which aligns with AmerisourceBergen's established role as a critical federal pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued on September 12, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $10,853.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was made competitively without set-aside designation to the Conshohocken,...
- The Defense Logistics Agency awarded a $5,012.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for ProQuad vials, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, commonly used across military and...
- The Defense Logistics Agency awarded a $5,480.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of May 12, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB26FSUEJDelivery Order
The Defense Logistics Agency awarded a $16,874.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of November 13, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, making this delivery order part of AmerisourceBergen's comprehensive pharmaceutical and medical supply support to the Department of Defense healthcare system. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs for military and veteran healthcare systems, with a demonstrated portfolio of vaccine and specialty medication deliveries. This delivery order exemplifies the company's ongoing role as a prime vendor supporting the Defense Health Agency and other federal healthcare entities through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 10/22/25 |